Insulet Corporation NMS · PODD
Price alert —
Sign in to get a one-time email the moment PODD crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · PODD
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.8B | $0.1B | $0.1B | $0.1B | 12.0% | 16.0% |
| 2025-12-31 | $0.8B | $0.1B | $0.1B | $0.0B | 13.0% | 18.7% |
| 2025-09-30 | $0.7B | $0.1B | $0.1B | $0.1B | 12.4% | 16.7% |
| 2025-06-30 | $0.6B | $0.0B | $0.1B | $0.2B | 3.5% | 18.7% |
| 2025-03-31 | $0.6B | $0.0B | $0.1B | $0.0B | 6.2% | 15.6% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare PODD vs peers
Line PODD up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with PODD
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-06 | 1.42 | 1.19 | +19.3% | +6.0% |
| 2026-02-18 | 1.55 | 1.46 | +6.0% | -3.5% |
| 2025-11-06 | 1.24 | 1.15 | +8.1% | -1.1% |
| 2025-08-07 | 1.17 | 0.92 | +26.8% | +1.2% |
| 2025-05-08 | 1.02 | 0.79 | +29.7% | +20.9% |
| 2025-02-20 | 1.15 | 1.02 | +12.6% | -1.9% |
| 2024-11-07 | 0.90 | 0.76 | +18.3% | +9.4% |
| 2024-08-08 | 0.55 | 0.56 | -2.5% | -8.8% |
| 2024-05-09 | 0.73 | 0.39 | +85.1% | -6.5% |
| 2024-02-22 | 1.40 | 0.66 | +111.4% | -6.6% |
| 2023-11-02 | 0.71 | 0.41 | +73.8% | +15.8% |
| 2023-08-08 | 0.38 | 0.26 | +43.4% | -3.6% |
| 2023-05-04 | 0.23 | 0.10 | +122.2% | +2.0% |
| 2023-02-23 | 0.55 | 0.19 | +188.9% | -1.1% |
| 2022-11-03 | 0.41 | 0.14 | +194.3% | +22.6% |
| 2022-08-04 | -0.08 | 0.23 | -133.6% | +4.3% |
| 2022-05-05 | 0.40 | 0.24 | +68.2% | -9.4% |
| 2022-02-23 | 0.43 | 0.33 | +29.0% | +10.6% |
| 2021-11-04 | 0.20 | 0.25 | -20.8% | +2.1% |
| 2021-08-05 | 0.15 | 0.14 | +13.8% | -1.8% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| PODD ★ | $11B | 38.3 | 20.4 | 3.9 | 19.8 | 8.7 | 71.0% | 33.9% | 159.0% | 2.23% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 44.12%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 6,375,943 | 9.21% |
| Vanguard Capital Management LLC | 4,579,274 | 6.61% |
| FMR, LLC | 3,974,712 | 5.74% |
| Vanguard Portfolio Management LLC | 3,449,987 | 4.98% |
| State Street Corporation | 3,042,454 | 4.39% |
| BAILLIE GIFFORD & CO | 2,029,492 | 2.93% |
| Geode Capital Management, LLC | 2,025,698 | 2.92% |
| T. Rowe Price Investment Management, | 1,815,742 | 2.62% |
| Capital Research Global Investors | 1,669,556 | 2.41% |
| AQR Capital Management, LLC | 1,598,724 | 2.31% |
Insider activity · 90d
13 buys / 1 sells · ratio 13.0 · Finnhub
- MAZELSKY JONATHAN JAY BUY 1,355
- Huffines Robert Luther BUY 2,442 @ $159.79
- Huffines Robert Luther BUY 2,449 @ $152.25
- STONESIFER TIMOTHY C. BUY 9,041 @ $143.51
- BORIO LUCIANA SELL 4,329 @ $143.27
- WEATHERMAN ELIZABETH H BUY 10,352 @ $144.20
- WEATHERMAN ELIZABETH H BUY 6,902
- STONESIFER TIMOTHY C. BUY 6,251
- Scannell Timothy J BUY 33,024
- MINOGUE MICHAEL R BUY 2,438
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-07-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-07-02 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-06-25 | 8-K | view · |
| 4 | 2026-06-04 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-04 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-03 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-05-26 | 8-K | view · |
| 4 | 2026-05-21 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-21 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-21 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-21 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-21 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-21 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-21 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-21 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-05-21 | 8-K | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 10-Q | 2026-05-06 | 10-Q | view · |
| 8-K | 2026-05-06 | 8-K | view · |
| 8-K | 2026-04-29 | 8-K | view · |
| DEF 14A | 2026-04-06 | DEF 14A | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-03-12 | 8-K | view · |
| 8-K | 2026-03-04 | 8-K | view · |
| 4 | 2026-03-03 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-03 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-03 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-03 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-03 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-26 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-23 | PRIMARY DOCUMENT | view · |
| 10-K | 2026-02-18 | 10-K | view · |
| 8-K | 2026-02-18 | 8-K | view · |
| 4 | 2026-02-17 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-17 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-17 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-17 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-17 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-02-03 | 8-K | view · |
| 4 | 2026-01-06 | PRIMARY DOCUMENT | view · |
| 4 | 2026-01-06 | PRIMARY DOCUMENT | view · |
| 8-K | 2025-12-19 | 8-K | view · |
| 8-K | 2025-12-17 | 8-K | view · |
| 4 | 2025-12-16 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-08 | PRIMARY DOCUMENT | view · |
| 10-Q | 2025-11-06 | 10-Q | view · |
| 8-K | 2025-11-06 | 8-K | view · |
| 4 | 2025-11-03 | PRIMARY DOCUMENT | view · |
| 8-K | 2025-10-23 | 8-K | view · |
| 4 | 2025-10-02 | PRIMARY DOCUMENT | view · |
| 8-K | 2025-09-16 | 8-K | view · |
About PODD
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Options picks · PODD
ITM + OTM ideas from the latest scanLoading…
Congress trades · PODD
STOCK Act disclosuresLoading…
SEC filings & insiders · PODD
EDGAR · liveLoading…
Holders · PODD
Institutions & insider activityLoading…